Aria CV Pulmonary Hypertension Acquires $31 Million for Feasibility Study

Aria CV Pulmonary Hypertension Acquires $31 Million for Feasibility Study

Aria CV Pulmonary Hypertension

February 27, 2020 — Aria CV Inc.completed a $31 million Series B round of financing to fund its first clinical study in the United States for an implantable device to treat pulmonary arterial hypertension (PAH). …

Sourced through Scoop.it from: www.dicardiology.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *